New clinical evidence: DILAPAN-S vs. balloon catheters
Share:
Recent studies provide new insights into cervical ripening methods, comparing DILAPAN-S with balloon catheters and reinforcing its clinical advantages.
We are glad to see new clinical evidence on DILAPAN-S comparing this synthetic osmotic dilator with both single and double balloon catheters, confirming its efficacy, safety profile, and maternal preference in both inpatient and outpatient settings
New publications and key findings
Lu et al.: Randomized control trial comparing hygroscopic cervical dilators to cervical ripening balloon for outpatient cervical ripening. AJOG MFM, April 2024 | DOI: 10.1016/j.ajogmf.2024.101318
- DILAPAN-S led to fewer early admissions and spontaneous expulsions, ensuring a more predictable induction process.
Leela et al.: Efficacy of Dilapan-S compared to Foley balloon in preinduction cervical ripening – a noninferiority trial. AJOG Global Reports, Nov 2024 | DOI: 10.1016/j.xagr.2024.100387
- No cases of cord prolapse were observed in the DILAPAN-S group, resulting in the authors´ conclusion that „DILAPAN-S can be prescribed as safer alternative to Foley balloon“.
Wood et al.: Cervical balloon catheter versus Dilapan-S for outpatient cervical ripening: A randomized controlled trial. AJOG MFM, Jan 2025 | DOI: 10.1016/j.ajogmf.2025.101608
- Patients using DILAPAN-S reported higher satisfaction and fewer unscheduled medical contacts, optimizing healthcare resources.
We are happy to see that DILAPAN-S keeps proving to be a gentle, effective, and patient-preferred option for cervical ripening
For further details, visit https://www.dilapan.com/healthcare-professionals/resources/
Other recommended News
Other news
Upcoming events
- 28.3.
- LIVE WEBINAR
- 16.12.
- LIVE WEBINAR
- 20. 11.
- LIVE WEBINAR
- 29. 11.
- LIVE WEBINAR
- 27. 9.
- LIVE WEBINAR
- 8. 5.
